Danaher Co. (NYSE:DHR) Director Walter G. Lohr sold 10,578 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $97.90, for a total transaction of $1,035,586.20. Following the transaction, the director now owns 19,821 shares in the company, valued at approximately $1,940,475.90. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Shares of Danaher Co. (NYSE:DHR) traded down $0.62 on Wednesday, reaching $102.18. 1,512,607 shares of the company were exchanged, compared to its average volume of 2,654,978. Danaher Co. has a fifty-two week low of $78.97 and a fifty-two week high of $104.82. The firm has a market capitalization of $71,330.00, a P/E ratio of 29.21, a price-to-earnings-growth ratio of 2.17 and a beta of 1.04. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.05 and a current ratio of 1.43.
Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $1.19 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.16 by $0.03. Danaher had a net margin of 13.60% and a return on equity of 11.36%. The firm had revenue of $5.09 billion for the quarter, compared to the consensus estimate of $4.97 billion. During the same period in the previous year, the company earned $1.05 earnings per share. The company’s quarterly revenue was up 10.9% on a year-over-year basis. analysts predict that Danaher Co. will post 4.37 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Thursday, March 29th will be paid a $0.16 dividend. The ex-dividend date of this dividend is Wednesday, March 28th. This is an increase from Danaher’s previous quarterly dividend of $0.14. This represents a $0.64 annualized dividend and a dividend yield of 0.63%. Danaher’s dividend payout ratio is 16.00%.
Hedge funds have recently added to or reduced their stakes in the stock. Optimum Investment Advisors lifted its holdings in shares of Danaher by 1.8% in the second quarter. Optimum Investment Advisors now owns 14,134 shares of the conglomerate’s stock worth $1,193,000 after acquiring an additional 250 shares during the last quarter. Williams Jones & Associates LLC lifted its holdings in shares of Danaher by 6.5% in the second quarter. Williams Jones & Associates LLC now owns 714,531 shares of the conglomerate’s stock worth $60,299,000 after acquiring an additional 43,348 shares during the last quarter. Cramer Rosenthal Mcglynn LLC increased its stake in shares of Danaher by 101.2% in the second quarter. Cramer Rosenthal Mcglynn LLC now owns 1,122,139 shares of the conglomerate’s stock valued at $94,697,000 after buying an additional 564,470 shares during the period. Prudential PLC increased its stake in shares of Danaher by 28.1% in the second quarter. Prudential PLC now owns 1,009,309 shares of the conglomerate’s stock valued at $85,176,000 after buying an additional 221,300 shares during the period. Finally, Financial Enhancement Group LLC increased its stake in shares of Danaher by 3.2% in the second quarter. Financial Enhancement Group LLC now owns 59,279 shares of the conglomerate’s stock valued at $5,003,000 after buying an additional 1,811 shares during the period. Institutional investors and hedge funds own 77.83% of the company’s stock.
A number of analysts have weighed in on DHR shares. Credit Suisse Group increased their price target on shares of Danaher from $106.00 to $108.00 and gave the company an “outperform” rating in a report on Tuesday. Deutsche Bank reduced their price objective on shares of Danaher from $114.00 to $107.00 and set a “buy” rating for the company in a report on Thursday, March 1st. Royal Bank of Canada reissued a “hold” rating and set a $98.00 price target on shares of Danaher in a report on Wednesday, January 31st. Stifel Nicolaus reissued a “buy” rating and set a $110.00 price target on shares of Danaher in a report on Friday, January 19th. Finally, Morgan Stanley lifted their price target on shares of Danaher from $103.00 to $110.00 and gave the company an “overweight” rating in a report on Wednesday, January 31st. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Danaher currently has an average rating of “Buy” and a consensus target price of $101.40.
COPYRIGHT VIOLATION NOTICE: This article was originally posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this article can be viewed at https://ledgergazette.com/2018/03/14/insider-selling-danaher-co-dhr-director-sells-10578-shares-of-stock.html.
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.